Stay updated on Tolebrutinib in NRSPMS Clinical Trial

Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Two new Gurgaon, India locations (122001 and 122002) were added and the Gūrgaon spellings for these entries were removed.
    Difference
    0.0%
    Check dated 2026-03-03T10:36:01.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-17T03:52:22.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.1 and the previous funding-lapse notice (v3.4.0) was removed.
    Difference
    0.1%
    Check dated 2026-02-09T22:41:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Two study location entries in India (122001 and 122002) were updated from Gurgaon to the diacritic spelling Gūrgaon in the study's locations list.
    Difference
    0.1%
    Check dated 2026-02-02T19:57:01.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Glossary display toggle has been added to the page. Updated labels and revision information include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision note 'v3.4.0' replacing the previous 'v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-26T22:18:54.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no visible edits to the study details or page functionality.
    Difference
    0.0%
    Check dated 2026-01-19T19:02:08.000Z thumbnail image

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.